Average Co-Inventor Count = 3.81
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (15 from 665 patents)
2. Incyte Holdings Corporation (10 from 147 patents)
3. Incyte Holdings Comoration (1 from 1 patent)
16 patents:
1. 12226419 - Topical formulation for a JAK inhibitor
2. 12151026 - Sustained release dosage forms for a JAK1 inhibitor
3. 11896717 - Sustained-release dosage forms of ruxolitinib
4. 11590136 - Topical formulation for a JAK inhibitor
5. 11576864 - Sustained-release dosage forms of ruxolitinib
6. 11576865 - Sustained-release dosage forms of ruxolitinib
7. 11571425 - Topical formulation for a JAK inhibitor
8. 11337927 - Sustained-release dosage forms of ruxolitinib
9. 11219624 - Topical formulation for a JAK inhibitor
10. 11045421 - Sustained release dosage forms for a JAK1 inhibitor
11. 10874616 - Sustained-release dosage forms of ruxolitinib
12. 10869870 - Topical formulation for a JAK inhibitor
13. 10758543 - Topical formulation for a JAK inhibitor
14. 10561616 - Sustained release dosage forms for a JAK1 inhibitor
15. 10166191 - Sustained-release dosage forms of ruxolitinib